| Section 1: Introduction | |
| | 2 | (3) |
| The Five Most Important Conclusions of This Book |
| | 5 | |
| The Role of Independent Analyses in Research on Toxic Agents |
| | 2 | (1) |
| | 3 | |
| Section 2: The Atomic-Bomb Survivors-A Study and Its Alteration | |
| Overview of a Uniquely Valuable Database |
| | 2 | (9) |
| A Growing Problem: Retroactive Alteration of the Study |
| | 11 | |
| What Will Happen to the A-Bomb Database? A Pending Proposal |
| | 2 | (1) |
| Section 3: Preparing the Database for Analysis | |
| Collecting All the Required Data from RERF |
| | 2 | (7) |
| Dosimetry: From Bomb, to Kerma, to Internal Organ-Dose |
| | 9 | |
| Converting T65DR Mean Kerma Values to Mean Internal Organ-Doses |
| | 2 | (1) |
| Obtaining Mean DS86 Doses for the T65DR Cohorts |
| | 2 | (2) |
| Achievement of Age-and Sex-Matching across the Dose-Groups |
| | 4 | (1) |
| Section 4: Cancer-Risk and Dose-Response in Both Dosimetries | |
| The Focus on Two Central Questions |
| | 5 | (2) |
| Analysis and Results by the Cancer Difference Method |
| | 7 | (2) |
| Shape of the Dose-Response Relationship, and Low-Dose Cancer-Yields Based on the Best-Fit Curve |
| | 9 | (1) |
| Radiation Risk by Age and Sex, from the Cancer-Rate Ratio Method |
| | 9 | |
| Low-Dose Cancer-Yields by the Cancer-Rate Ratio Method, for A-Bomb Survivors and for the United States |
| | 5 | (4) |
| The Duration of Radiation's Carcinogenic Effect |
| | 9 | (9) |
| Section 5: Disproof of Any Safe Dose or Dose-Rate | |
| Disproof of Any Safe Dose or Dose-Rate of lonizing Radiation, with Respect to Induction of Cancer in Humans |
| | 18 | |
| Auxiliary Chapters on the Threshold Issue |
| |
| The Special Interaction of lonizing Radiation with Living Tissue |
| | 8 | |
| Various Radiation Sources: Primary Electron-Tracks per Nucleus per Rad |
| | 7 | (13) |
| Decisive Epidemiological Evidence from Humans |
| | 20 | (5) |
| Section 6: The Fallacy of Risk-Reduction Factors for Low and Slow Exposures | |
| The Popularity of Risk-Reduction Factors in the Radiation Community |
| | 25 | |
| Proper Risk-Estimates for ``Low and Slow'' Exposures: No Conflict between Human Epidemiology and the Linear-Quadratic Hypothesis from Radiobiology |
| | 15 | (5) |
| Section 7: Practical Impacts on Human Health | |
| Chernobyl: A Crossroad in the Radiation Health Sciences |
| | 20 | |
| Main Text: A Closing Statement |
| | 17 | |
| Section 8: Supporting Chapters | |
| Master Table and Special RERF Data for the A-Bomb Study |
| | 1 | (3) |
| Significance of Elevated Cancer Death-Rate in Various Dose-Groups, and Confidence-Limits on Cancer-Yields (Cancer Difference Method) |
| | 4 | |
| Estimated Spontaneous Cancer-Mortality in the A-Bomb Reference Group, for a Completed Lifespan Follow-Up |
| | 2 | (2) |
| Curvilinear Regression and Equations of Best Fit |
| | 4 | |
| The Shape of Dose-Response, in Cancers per 10,000 Person-Years |
| | 1 | (2) |
| Dose-Increment for Small Body-Size in Age-Band 0-9 Years ATB |
| | 3 | (1) |
| Calculation of Primary Electrons per Photon, and Their Energies |
| | 3 | (7) |
| Calculation of Range for Each High-Speed Electron |
| | 10 | |
| Allusions to the Possible Existence of Safe Doses and Dose-Rates |
| | 9 | (12) |
| Hormesis: The Nature of Speculations about Undemonstrated ``Beneficial Effects'' |
| | 21 | (12) |
| Assessing Chernobyl's Cancer Consequences, September 9, 1986 |
| | 33 | |
| Membership on Various Radiation Committees |
| | 9 | (1) |
| References | | 10 | (2) |
| Index and Glossary | | 12 | |
